Author
Listed:
- Andrew Roe
(Royal College of Surgeons in Ireland)
- Catríona M. Dowling
(Royal College of Surgeons in Ireland)
- Cian D’Arcy
(Royal College of Surgeons in Ireland)
- Daniel Alencar Rodrigues
(Royal College of Surgeons in Ireland)
- Yu Wang
(Royal College of Surgeons in Ireland)
- Matthew Hiller
(Royal College of Surgeons in Ireland)
- Carl Keogh
(Royal College of Surgeons in Ireland)
- Kate E. R. Hollinshead
(New York University Langone Medical Center)
- Massimiliano Garre
(Royal College of Surgeons in Ireland)
- Brenton Cavanagh
(Royal College of Surgeons in Ireland)
- Kieran Wynne
(Belfield
University College Dublin)
- Tianyan Liu
(Peking University)
- Zhixing Chen
(Peking University)
- Emma Kerr
(Queen’s University)
- Marie McIlroy
(Royal College of Surgeons in Ireland)
- Jochen H. M. Prehn
(Royal College of Surgeons in Ireland)
- Ingmar Schoen
(Royal College of Surgeons in Ireland)
- Tríona Ní Chonghaile
(Royal College of Surgeons in Ireland)
Abstract
Fumarate hydratase (FH), a key node of mitochondrial metabolism, is also a tumour suppressor. Despite its prominent roles in tumourigenesis and inflammation, its regulation remains poorly understood. Herein, we show that histone deacetylase 6 (HDAC6) regulates FH activity. In triple-negative breast cancer cells, HDAC6 inhibition or knockdown results in alterations to mitochondrial cristae structure, as detected by live-cell super-resolution STED nanoscopy and electron microscopy, along with the release of mitochondrial DNA. Mass-spectrometry immunoprecipitation reveals multiple mitochondrial HDAC6-interactors, with FH emerging as a top hit. Super-resolution 3D-STORM shows HDAC6 interactions with FH in mitochondrial networks, which increases after perturbation of HDAC6 activity with BAS-2. Treatment with BAS-2 leads to fumarate accumulation by 13C glucose labelling, along with downstream succination of proteins and cell death. Together, these results identify HDAC6 inhibition as a regulator of endogenous FH activity in tumour cells, and highlight it as a promising candidate for indirectly targeting tumour metabolism.
Suggested Citation
Andrew Roe & Catríona M. Dowling & Cian D’Arcy & Daniel Alencar Rodrigues & Yu Wang & Matthew Hiller & Carl Keogh & Kate E. R. Hollinshead & Massimiliano Garre & Brenton Cavanagh & Kieran Wynne & Tian, 2025.
"Inhibition of HDAC6 alters fumarate hydratase activity and mitochondrial structure,"
Nature Communications, Nature, vol. 16(1), pages 1-17, December.
Handle:
RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-61897-6
DOI: 10.1038/s41467-025-61897-6
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-61897-6. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.